Isomorphic Labs, the AI drug research company led by DeepMind co-founder Demis Hassabis, has closed a $2.1 billion Series B round led by Thrive Capital. The funding will go toward expanding its in-house platform IsoDDE and advancing drug candidates toward clinical trials.<br /> The article Alphabet's Isomorphic Labs raises $2.1 billion to scale AI drug discovery toward clinical trials appeared first on The Decoder. [...]
Isomorphic Labs, Google DeepMind's AI medicine startup, has unveiled a new system called "Isomorphic Labs Drug Design Engine" (IsoDDE) that it says doubles AlphaFold 3's accuracy f [...]
Isomorphic Labs, a Deepmind spin-off focused on drug discovery, is getting ready for its first clinical trials with drugs designed using AlphaFold-based AI models.<br /> The article Isomorphic L [...]
Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups race to turn algorithmic magic into actual treatments. “We’ll hopefully [...]
Today, Copenhagen-based healthcare AI Corti is launching Symphony for Speech-to-Text, a new generation of clinical-grade speech recognition models engineered specifically for real-time dictation, conv [...]
Modern medicine is a marvel, with previously unimaginable cures and treatments now widely available. Think of advanced medical devices such as implantable defibrillators that help regulate heart rhyth [...]
Endor Labs, the application security startup backed by more than $208 million in venture funding, today launched AURI, a platform that embeds real-time security intelligence directly into the AI codin [...]
Earlier this summer Engadget covered the news that Warner Bros. Discovery would split into two giant media companies. Today the conglomerate announced the names for the restructured entities.<br /& [...]